TAGStone Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$939K Sell
783
-26
-3% -$26.6K 0.3% 60
2026
Q1
$744K Buy
809
+186
+30% +$189K 0.26% 68
2025
Q4
$670K Buy
623
+1
+0.2% +$956 0.25% 72
2025
Q3
$475K Buy
622
+1
+0.2% +$744 0.19% 79
2025
Q2
$389K Buy
621
+101
+19% +$78.5K 0.16% 87
2025
Q1
$430K Buy
520
+1
+0.2% +$832 0.21% 68
2024
Q4
$401K Hold
519
– – 0.2% 67
2024
Q3
$459K Buy
519
+1
+0.2% +$899 0.23% 64
2024
Q2
$469K Buy
518
+4
+0.8% +$3.2K 0.27% 62
2024
Q1
$400K Buy
514
+1
+0.2% +$712 0.23% 64
2023
Q4
$299K Buy
513
+1
+0.2% +$584 0.2% 71
2023
Q3
$275K Buy
512
+1
+0.2% +$515 0.2% 72
2023
Q2
$240K Buy
+511
New +$214K 0.17% 74

Other funds holding LLY

TAGStone Capital's LLY Position: Q2 2026 in Review

TAGStone Capital reduced its Eli Lilly (LLY) stake by 3.2% in Q2 2026, selling an estimated $26.6K and leaving 783 shares worth $939K. The position accounts for 0.3% of the portfolio, ranked #60.

TAGStone Capital first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • TAGStone Capital held 783 shares of Eli Lilly worth $939K as of Q2 2026.
  • TAGStone Capital sold 26 Eli Lilly shares in Q2 2026, an estimated $26.6K.
  • Eli Lilly made up 0.3% of TAGStone Capital's portfolio in Q2 2026, its #60 holding.
  • TAGStone Capital first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on TAGStone Capital's 13F filing for Q2 2026, filed 11 Aug 2026.